Hepatic flavin-containing monooxygenase activity attenuated by cGMP-independent nitric oxide-mediated mRNA destabilization

Flavin-containing monooxygenase activity can be inhibited by nitric oxide-mediated S-nitrosylation

Inhibition of aroclor 1254-induced depletion of stored calcium prevents the cell death in catecholaminergic cells

Alteration of substrate specificity by common variants, E158K/E308G and V257M, in human hepatic drug-metabolizing enzyme, flavin-containing monooxygenase 3

Aroclor 1254-induced cytotoxicity in catecholaminergic CATH.a cells related to the inhibition of NO production

Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO

The development of tolerance to and dependence on morphine are reduced by co-administration of nalbuphine in rat

Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: Determination by caffeine metabolism

Phenotypes of flavin-containing monooxygenase (FMO) activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FMO3 gene mutations in a Korean population

Differential and constitutive expression of neuronal, inducible and endothelial nitric oxide synthase mRNAs and proteins in pathologically normal human tissues